Elise A. Chong

Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas

Stephen J. Schuster, Jakub Svoboda, Elise A. Chong et al. · New England Journal of Medicine · 2017 · 1.9K citations · Full text

Life Sciences, Hematology, Immunology +17

Outcomes of COVID-19 in patients with CLL: a multicenter international experience

Anthony R. Mato, Lindsey E. Roeker, Nicole Lamanna et al. · Blood · 2020 · 318 citations · Full text

Pharmacy, Health Sciences, Internal Medicine +3

Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

Melody Smith, Anqi Dai, Guido Ghilardi et al. · Nature Medicine · 2022 · 309 citations · Full text

Life Sciences, Immunology, Microbiology +14

T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy

Guido Ghilardi, Joseph A. Fraietta, James N. Gerson et al. · Nature Medicine · 2024 · 256 citations

Life Sciences, Immunology, Oncology +16

Vaccination With Patient-Specific Tumor-Derived Antigen in First Remission Improves Disease-Free Survival in Follicular Lymphoma

Stephen J. Schuster, Sattva S. Neelapu, Barry L. Gause et al. · Journal of Clinical Oncology · 2011 · 243 citations · Full text

Medicine, Immunology, Oncology +17